Targeting cytokines beyond tumor necrosis factor-α and interleukin-1 in rheumatoid arthritis
✍ Scribed by Iain B. McInnes; J. Alastair Gracie
- Book ID
- 107549331
- Publisher
- Springer
- Year
- 2005
- Tongue
- English
- Weight
- 324 KB
- Volume
- 9
- Category
- Article
- ISSN
- 1534-3081
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
With concomitant methotrexate. † Pegylated recombinant methionyl human soluble tumor necrosis factor type I.
## Objective: To investigate the regulation of expression of the angiogenic cytokine vascular endothelial growth factor (vegf) in rheumatoid arthritis (ra), in order to determine whether new blood vessel formation could be a potential therapeutic target in ra. ## Methods: Dissociated ra synovial
COPD ϭ chronic obstructive pulmonary disease. 300 Letters \* RA ϭ rheumatoid arthritis; JRA ϭ juvenile rheumatoid arthritis; ESR ϭ erythrocyte sedimentation rate; CRP ϭ C-reactive protein; VAS ϭ visual analog scale; GH ϭ general health; DAS28 ϭ Disease Activity Score in 28 joints; HAQ ϭ Health Asses